Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
ipo
5
×
national blog main
5
×
national top stories
texas blog main
5
×
texas top stories
vc
5
×
venture capital
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
biogen
celgene
fda
funding
gene editing
novartis
biomarin pharmaceutical
cancer
car-t
commissioner
What
bio
roundup
ipo
new
activity
agtech
allogene
approvals
based
becker
billions
biogen
biopharma
blockchain
cancer
car
caught
celgene
chargify
clamped
colleagues
company
covid
crispr
delays
developing
diversity
dollars
eaton
economic
exome
fast
fda
gene
government
grainchain
grande
health
healthcare
hot
Language
unset
Current search:
ipo
×
vc
×
" national blog main "
×
" texas blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
GrainChain, Chargify, Q2, Hypergiant, NASA Tech & More TX Tech
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More